| Enhancing Recombinant Protein Yields in the E. coli Periplasm by Combining Signal Peptide and Production Rate Screening A Karyolaimos, H Ampah-Korsah, T Hillenaar, A Mestre Borras, ... Frontiers in microbiology 10, 1511, 2019 | 56 | 2019 |
| Escherichia coli Can Adapt Its Protein Translocation Machinery for Enhanced Periplasmic Recombinant Protein Production A Karyolaimos, KM Dolata, M Antelo-Varela, A Mestre Borras, R Elfageih, ... Frontiers in Bioengineering and Biotechnology 7, 465, 2020 | 10 | 2020 |
| Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules SS Rinne, W Yin, AM Borras, A Abouzayed, CD Leitao, A Vorobyeva, ... Biomedicines 10 (6), 1293, 2022 | 6 | 2022 |
| Generation of an anti-idiotypic affibody-based masking domain for conditional activation of EGFR-targeting AM Borras, CD Leitao, S Ståhl, J Löfblom New Biotechnology 73, 9-18, 2023 | 4 | 2023 |
| Engineering of TEV protease variants with redesigned substrate specificity SW Meister, L Parks, L Kolmar, AM Borras, S Ståhl, J Löfblom Biotechnology Journal, 2200625, 2023 | 3 | 2023 |
| Conditionally activated affibody-based prodrug targeting EGFR demonstrates improved tumour selectivity CD Leitao, AM Borras, T Xu, M Oroujeni, Y Liu, C Westerberg, J Clinton, ... Journal of Controlled Release 357, 185-195, 2023 | 2 | 2023 |
| HER3-targeted drug delivery: Preclinical characterization of (HE) 3-ZHER3-ABD-mcDM1 using Tc-99m S Rinne, A Abouzayed, W Yin, A Mestre Borras, CD Leitao, A Vorobyeva, ... European Journal of Nuclear Medicine and Molecular Imaging 49 (SUPPL 1 …, 2022 | | 2022 |
